Hiroshi Keino Selected Research

Hiroshi Keino Research Topics

Disease

17	Inflammation (Inflammations) 01/2021 - 02/2003
13	Uveitis 01/2020 - 09/2002
6	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 02/2022 - 02/2010
5	Retinal Perforations 03/2022 - 12/2008
4	Behcet Syndrome (Behcet's Syndrome) 02/2017 - 10/2006
3	Hypersensitivity (Allergy) 09/2009 - 02/2007
2	Retinal Detachment (Retinal Detachments) 01/2022 - 01/2015
2	Optic Atrophy 01/2022 - 01/2015
2	Necrosis 01/2020 - 02/2007
2	Scleritis (Episcleritis) 03/2011 - 11/2008
2	Delayed Hypersensitivity (Hypersensitivity, Type IV) 08/2004 - 09/2002
1	Cataract (Cataracts) 10/2022
1	Sarcoidosis (Schaumann Disease) 10/2022
1	COVID-19 02/2022
1	Disease Progression 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Cushing Syndrome 02/2017
1	Iridocyclitis 02/2017
1	Glaucoma 01/2017
1	Optic Neuritis (Retrobulbar Neuritis) 08/2015
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 08/2015
1	Fibrosis (Cirrhosis) 03/2015
1	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2015
1	Arteritis 01/2015
1	Hyperemia 01/2015
1	Neovascular Glaucoma 01/2011
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2011
1	Neoplasm Metastasis (Metastasis) 01/2011
1	Panuveitis 02/2010
1	Neoplasms (Cancer) 09/2009
1	Endophthalmitis (Ophthalmia) 11/2008
1	Arthritis (Polyarthritis) 09/2003
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2003
1	Dermatitis 09/2002
1	Anterior Uveitis 09/2002
1	Acute Retinal Necrosis Syndrome 09/2002
1	Skin Diseases (Skin Disease) 09/2002
1	Zoster Sine Herpete 09/2002
1	Herpes Zoster 09/2002
1	Herpes Zoster Ophthalmicus 09/2002

Drug/Important Bio-Agent (IBA)

6	Retinaldehyde (Retinal)IBA 01/2022 - 12/2008
5	Infliximab (Remicade)FDA Link 02/2017 - 09/2011
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 11/2008
3	fosfestrol (Kyorin)FDA Link 10/2022 - 01/2017
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2022 - 11/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 02/2008
3	Interferon-gamma (Interferon, gamma)IBA 03/2011 - 02/2007
3	Proteins (Proteins, Gene)FDA Link 02/2008 - 09/2002
2	MicroRNAs (MicroRNA)IBA 03/2022 - 03/2015
2	Antiviral Agents (Antivirals)IBA 02/2022 - 01/2015
2	CytokinesIBA 01/2021 - 05/2009
2	Peptides (Polypeptides)IBA 01/2017 - 08/2004
2	tamibaroteneIBA 08/2015 - 03/2011
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2015 - 06/2010
2	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 08/2015 - 03/2011
2	Vitamin A (Retinol)FDA LinkGeneric 01/2012 - 06/2010
2	Bevacizumab (Avastin)FDA Link 01/2011 - 03/2009
2	apilimodIBA 11/2010 - 01/2008
2	ChemokinesIBA 03/2010 - 02/2003
2	AntigensIBA 09/2009 - 09/2002
1	Biomarkers (Surrogate Marker)IBA 03/2022
1	Ointments (Pastes)IBA 01/2021
1	dehydroxymethylepoxyquinomicinIBA 01/2020
1	EndotoxinsIBA 01/2020
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 11/2018
1	Interleukin-10 (Interleukin 10)IBA 03/2017
1	Ophthalmic Solutions (Eye Drops)IBA 02/2017
1	GlucocorticoidsIBA 02/2017
1	betamethasone sodium phosphate FDA LinkGeneric 02/2017
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2017
1	Interleukin-22 (IL-22)IBA 06/2013
1	RetinoidsIBA 03/2011
1	NF-kappa B (NF-kB)IBA 11/2010
1	KIR ReceptorsIBA 02/2010
1	Fas Ligand Protein (Fas Ligand)IBA 02/2008
1	Interleukin-12 (IL 12)IBA 01/2008
1	Interleukin-8 (Interleukin 8)IBA 01/2008
1	OvalbuminIBA 06/2007
1	Tacrolimus (Prograf)FDA LinkGeneric 02/2007
1	Transforming Growth Factor beta2IBA 10/2006
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 09/2003
1	Chemotactic FactorsIBA 02/2003
1	Tuberculin (PPD)IBA 09/2002

Therapy/Procedure

7	Therapeutics 01/2019 - 09/2011
2	Injections 01/2019 - 11/2018
2	Oral Administration 11/2010 - 01/2008
2	Intravitreal Injections 03/2009 - 02/2007
1	Vitrectomy 10/2022
1	Corneal Transplantation (Keratoplasty) 01/2019
1	Remission Induction 02/2017
1	Cataract Extraction 01/2017
1	Slit Lamp 02/2007